Intervertebral Disc Degeneration and Cross-Talk with the Nervous System
椎间盘退变和与神经系统的交互作用
基本信息
- 批准号:10412615
- 负责人:
- 金额:$ 5.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:AlginatesAttenuatedAzidesBiocompatible MaterialsBiomedical EngineeringCardiovascular systemCell Culture TechniquesChemistryCouplingDevelopmentDevelopment PlansDisease modelDrug Delivery SystemsEducationEducational workshopEngineeringEnvironmentGelGoalsHydrogelsIndividualInjectableIntervertebral disc structureKineticsKnowledgeLow Back PainMentorsMentorshipModificationMusculoskeletalNerve Growth FactorsNervous system structureNeuronsPainPharmaceutical PreparationsPlant RootsPost Graduate YearPre-Clinical ModelRegenerative MedicineResearchResearch ActivityResearch Project GrantsResourcesSchoolsScientistSpinal GangliaTraining ActivityUniversitiesWashingtonWorkafferent nervecalcium indicatordesignexperiencegraduate studentintervertebral disk degenerationmedical schoolsmouse modelnovelpain reliefparent grantperineuralskillsspinal nerve posterior rootsuccesssymposiumtransmission process
项目摘要
Intervertebral disc (IVD) degeneration is one of the greatest contributors to low back pain, yet how the IVD can
generate pain remains poorly understood. The parent grant will pursue Specific Aims to study the development
of temporal and spatial changes in neuronal function and their “cross-talk” with changes in the degenerating IVD
in a mouse model of lumbar IVD degeneration. Here, we propose a supplemental project called “Novel Injectable
Hydrogels for Localized Pain Relief in the Dorsal Root Ganglion (DRG)” that will support Ms. Sydney Neal in the
design of a novel injectable drug depot in order to attenuate neuronal sensitivity with lumbar IVD degeneration.
The overall goal is for Ms. Neal, a graduate student in biomedical engineering, to develop a novel
chemistry that will couple the nerve growth factor (NGF) antagonist, Tanuzemab, to an injectable, gelling alginate
to provide for local release of an NGF antagonist at the lumbar DRGs with IVD degeneration. In Supplemental
Aim 1, Ms. Neal will modify binary mixtures of alginate and evaluate gelation kinetics and localization to the
DRGs following simulated perineural delivery. In Supplemental Aim 2, Ms. Neal will develop a strategy to
couple Tanezumab to alginate using an azide modification and evaluate the efficiency of coupling. In
Supplemental Aim 3, Ms. Neal will evaluate the bioactivity of the drug-conjugated alginate hydrogels in isolated
DRG neurons subjected to periods of incubation with NGF. Ms. Neal will be co-sponsored by Dr. Nate Huebsch
who brings experience with biomaterials and drug delivery to the team, and Dr. Lori Setton who brings experience
with IVD degeneration and perineural drug delivery to the team.
During the period of this project, Ms. Neal will gain new and valuable skills in neuronal cell culture,
genetically-encoded calcium indicators, pre-clinical models of disease development, and work closely with
clinicians to increase her knowledge of treatment relevance for engineered biomaterials. Ms. Neal will further
prepare an Individual Development Plan, participate in workshops for research success at Washington
University, attend national conferences to present her work, and have an opportunity to participate in a national
conference to mentor Black scientists. Washington University provides an excellent environment for the
completion of this research project and continued professional development of Ms. Sydney Neal. Ms. Neal will
work within the McKelvey School of Engineering and the School of Medicine and participate in resources of the
Musculoskeletal Research Center, the Cardiovascular Research Center, and the Center for Regenerative
Medicine. In all, these combined research and training activities are designed to prepare Ms. Neal for continued
academic research in her post-graduate years.
椎间盘(IVD)退变是导致腰痛的最大原因之一,但它是如何做到的呢
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lori A. Setton其他文献
Evaluierung von Knorpelmarkern nach Meniskektomie im longitudinalen Verlauf
纵向评估
- DOI:
- 发表时间:
1997 - 期刊:
- 影响因子:0
- 作者:
E. Lindhorst;Thomas P. Vail;Farshid Guilak;Lori A. Setton;Sean P. Scully;V. Byers;L. Gotzen - 通讯作者:
L. Gotzen
Chapter 62: TISSUE ENGINEERING FOR REGENERATION AND REPLACEMENT OF THE INTERVERTEBRAL DISC (In press, Principles of Tissue Engineering, (eds) RP Lanza, R Langer and J Vacanti. Academic Press, 4 th edition)
第 62 章:椎间盘再生和替换的组织工程(出版中,《组织工程原理》,(编辑)RP Lanza、R Langer 和 J Vacanti。学术出版社,第 4 版)
- DOI:
- 发表时间:
2006 - 期刊:
- 影响因子:0
- 作者:
Lori A. Setton;Lawrence Bonassar;Koichi Masuda - 通讯作者:
Koichi Masuda
A genetically engineered thermally responsive sustained release curcumin depot to treat neuroinflammation
- DOI:
10.1016/j.jconrel.2013.06.032 - 发表时间:
2013-10-10 - 期刊:
- 影响因子:
- 作者:
S. Michael Sinclair;Jayanta Bhattacharyya;Jonathan R. McDaniel;David M. Gooden;Ramesh Gopalaswamy;Ashutosh Chilkoti;Lori A. Setton - 通讯作者:
Lori A. Setton
Correction to: Size-Dependent Effective Diffusivity in Healthy Human and Porcine Joint Synovium
- DOI:
10.1007/s10439-022-02939-8 - 发表时间:
2022-02-27 - 期刊:
- 影响因子:5.400
- 作者:
Young Guang;Alexandra L. Davis;Thomas M. McGrath;Christine T. N. Pham;James A. J. Fitzpatrick;Lori A. Setton - 通讯作者:
Lori A. Setton
Bestimmung des Chondroitinsulfatneoepitops 3B3(-) in Serum und Synovialflüssigkeit nach Meniskektomie: Prototyp des idealen Knorpelmarkers?
Bestimmung des Chondroitinsulfatneoepitops 3B3(-) in Serum und Synovialflüssigkeit nach Meniskektomie:理想 Knorpelmarkers 的原型?
- DOI:
- 发表时间:
1997 - 期刊:
- 影响因子:0
- 作者:
E. Lindhorst;Thomas P. Vail;Farshid Guilak;Lori A. Setton;V. Byers;L. Gotzen;A. Encke - 通讯作者:
A. Encke
Lori A. Setton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lori A. Setton', 18)}}的其他基金
Intervertebral Disc Degeneration and Cross-Talk with the Nervous System
椎间盘退变和与神经系统的交互作用
- 批准号:
10672264 - 财政年份:2020
- 资助金额:
$ 5.62万 - 项目类别:
Intervertebral Disc Degeneration and Cross-Talk with the Nervous System
椎间盘退变和与神经系统的交互作用
- 批准号:
10454431 - 财政年份:2020
- 资助金额:
$ 5.62万 - 项目类别:
Intervertebral Disc Degeneration and Cross-Talk with the Nervous System
椎间盘退变和与神经系统的交互作用
- 批准号:
10031377 - 财政年份:2020
- 资助金额:
$ 5.62万 - 项目类别:
Intervertebral Disc Degeneration and Cross-Talk with the Nervous System
椎间盘退变和与神经系统的交互作用
- 批准号:
10225556 - 财政年份:2020
- 资助金额:
$ 5.62万 - 项目类别:
Intervertebral Disc Degeneration and Cross-Talk with the Nervous System
椎间盘退变和与神经系统的交互作用
- 批准号:
10652003 - 财政年份:2020
- 资助金额:
$ 5.62万 - 项目类别:
Intervertebral Disc Degeneration and Cross-Talk with the Nervous System
椎间盘退变和与神经系统的交互作用
- 批准号:
10897489 - 财政年份:2020
- 资助金额:
$ 5.62万 - 项目类别:
Intra-Articular Delivery of Sustained Release NF-kB Antagonists in Arthritis
关节内缓释 NF-kB 拮抗剂治疗关节炎
- 批准号:
10092120 - 财政年份:2017
- 资助金额:
$ 5.62万 - 项目类别:
Biomedical Engineering Society 2017 Annual Meeting
生物医学工程学会2017年年会
- 批准号:
9398340 - 财政年份:2017
- 资助金额:
$ 5.62万 - 项目类别:
Engineering Microenvironments for the Nucleus Pulposus Cell
髓核细胞的工程微环境
- 批准号:
9228325 - 财政年份:2016
- 资助金额:
$ 5.62万 - 项目类别:
CELLULAR DELIVERY OF RAT INTERVERTEBRAL DISC CELLS IN DISC DEGENERATION MODEL
椎间盘退变模型中大鼠椎间盘细胞的细胞递送
- 批准号:
8363214 - 财政年份:2011
- 资助金额:
$ 5.62万 - 项目类别:
相似海外基金
A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
- 批准号:
24K02286 - 财政年份:2024
- 资助金额:
$ 5.62万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
- 批准号:
2420924 - 财政年份:2024
- 资助金额:
$ 5.62万 - 项目类别:
Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 5.62万 - 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
- 批准号:
10742028 - 财政年份:2023
- 资助金额:
$ 5.62万 - 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
- 批准号:
BB/X017540/1 - 财政年份:2023
- 资助金额:
$ 5.62万 - 项目类别:
Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
- 批准号:
LP210301365 - 财政年份:2023
- 资助金额:
$ 5.62万 - 项目类别:
Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
- 批准号:
10730832 - 财政年份:2023
- 资助金额:
$ 5.62万 - 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
- 批准号:
10659841 - 财政年份:2023
- 资助金额:
$ 5.62万 - 项目类别:
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
- 批准号:
BB/V016067/1 - 财政年份:2022
- 资助金额:
$ 5.62万 - 项目类别:
Research Grant
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
- 批准号:
576545-2022 - 财政年份:2022
- 资助金额:
$ 5.62万 - 项目类别:
Idea to Innovation














{{item.name}}会员




